Feed TFX
TF

Teleflex

TFX · NYSE

$125.67 +0.92% (+$1.15)
1M -9.97%
Market Cap $5.51B
P/E Ratio -
Div. Yield 1.09%
ROE 31.83%

Bulios Fair Price

$178.18

41.8% upside

Preț actual

$125.67

Subevaluat Valoare justă Supraevaluat

Potrivit Bulios Fair Price, acțiunile TFX sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?

Bulios Fair Price este o estimare a valorii corecte a unei acțiuni din modelul de evaluare Bulios. Este un punct de plecare pentru propria analiză, nu o recomandare de investiții. Cum funcționează?

Piotroski F-Score Moderate
5/9
Valuation
87 /100
Cheap
P/B 1.90x
P/FCF 14.11x
P/S 2.12x
Growth
6 /100
Declining
FCF growth 2.27%
Book val. growth 8.07%
Rev. growth 10.62%
Profitability
51 /100
Moderate
Net margin 39.58%
Op. margin 3.35%
FCF margin 15.02%
Quality
6 /100
Poor
ROE 31.83%
ROA 15.17%
Asset turnover 0.38x
Debt
47 /100
Moderate
Current ratio 2.60x
Int. coverage -2.85x
Debt/Equity 0.99x
Stability
40 /100
Moderate
Rev. volatility 22.68%
EPS volatility 824.86%
Profitable years 0

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre TFX
Online

Despre companie

Teleflex Incorporated (TFX) is an American company focused on the development, manufacturing, and distribution of innovative medical devices and products for surgery, anesthesia, cardiovascular care, respiratory therapy, and other fields. With a broad portfolio of products including surgical instruments, catheters, endoscopes, tubes, and ventilators, Teleflex is one of the leading suppliers of medical devices in the market. The company focuses on innovative design, reliability, and user-friendliness of its products to provide effective and safe solutions to physicians and patients. Teleflex also invests in research and development of new technologies and products to continuously improve healthcare and treatment procedures. Teleflex Incorporated (TFX) shares could be suitable for investors looking to invest in companies operating in the medical device sector with an emphasis on innovation, quality, and a wide range of products for various medical specialties.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Jason Weidman

Employees

15,500

Headquarters

Wayne

Evenimente viitoare

05 NOV.

Earnings

Upcoming earnings report

45d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.